Building successful life sciences companies.

With over $200 million of committed capital under management, Genesys is one of the largest Canadian-based exclusively focused on the life sciences industry. View our portfolio.

Building companies, accelerating development.

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.

Investor Login

Sign in to our secure investor area to receive personalized updates and information. Login now »

Recent Additions

Siemens Healthineers to Acquire Epocal from Alere to Complete Its Blood Gas Portfolio
NORWOOD, Mass., July 21, 2017 --(BUSINESS WIRE)-- Siemens Healthineers has entered into a definitive agreement to acquire Epocal Inc.,... Read more
Fusion Pharmaceuticals Launches with a $25M USD Series A Financing to Develop Targeted Radiotherapeutics as Cancer Treat
HAMILTON, ON, February 23, 2017 - Fusion Pharmaceuticals, a newly formed biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer,... Read more